FdaApplication
NDA 206111
Identifiers
- fda_app_no: NDA206111
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2015-08-26 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET;ORAL |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 12.5MG;500MG | TABLET;ORAL |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG;1GM | TABLET;ORAL |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 12.5MG;1GM | TABLET;ORAL |
4 products